Ranbaxy’s total R&D spend is around 6.5-7% of turnover...

However, survival on generics alone isn’t feasible either. So Indian companies are changing tracks. According to the Ranbaxy spokesperson, “Ranbaxy’s total R&D spend is around 6.5-7% of turnover... Company has a strong focus in New Drug Discovery Research & Novel Drug Delivery Systems.” Another instance is Dr. Reddy’s Laboratories, which allied with Clin Tec International to develop an anti-cancer drug.

For complete IIPM article click here

Source:- IIPM Editorial

Visit also:- IIPM Publication, Business & Economy & Arindam Chaudhuri Initiative